Solana Co — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2021-02-01

Reporting Person: ANDREEFF DANE (Director, Interim President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	A	6468	$14.81	Acquired	47054	Indirect
2021-02-01	Common Stock	A	2900	$14.81	Acquired	11498	Indirect
2021-02-01	Common Stock	A	5700	$14.81	Acquired	29009	Indirect
2021-02-01	Common Stock	A	1800	$14.81	Acquired	3484	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-01	Warrant (Right to Buy)	$16.302	A	3234	Acquired	2026-02-01	Common Stock (3234)	Indirect
2021-02-01	Warrant (Right to Buy)	$16.302	A	1450	Acquired	2026-02-01	Common Stock (1450)	Indirect
2021-02-01	Warrant (Right to Buy)	$16.302	A	2850	Acquired	2026-02-01	Common Stock (2850)	Indirect
2021-02-01	Warrant (Right to Buy)	$16.302	A	900	Acquired	2026-02-01	Common Stock (900)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	571	Direct

Footnotes

F1: The shares and warrants are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F2: The shares and warrants are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares and warrants are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F4: The shares and warrants are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities held by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F5: Immediately exercisable.